vs
Side-by-side financial comparison of Biodexa Pharmaceuticals Plc (BDRX) and GSK plc (GSK). Click either name above to swap in a different company.
Biodexa Pharmaceuticals Plc is a clinical-stage biopharmaceutical company focused on developing innovative therapies for central nervous system disorders, including epilepsy and rare neurodegenerative conditions. It operates primarily across European and North American markets, advancing multiple pipeline candidates through clinical trials to address unmet patient needs.
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
